Using multi-omics to characterize changes in inflammatory markers observed following GLP-1 therapy.
See how we used population-scale rLC-MS metabolomics data to develop an ML-based model to predict biological aging.
Describing the comprehensive, systematic quality matrix for QC in Sapient’s nontargeted mass spectrometry workflows.
This case study details the discovery of a biomarker of biological processes in patients with sequence-verified mitochondrial disease.
The inherent heterogeneity in patient populations can often lead to variable drug response. We recently worked with a client who…
The PD-1 pathway has transformed the development of immunotherapies as a means to reawaken the immune system to target cancer…
The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) continue to rise worldwide, estimated to affect over one-quarter of…
Immunotherapy has transformed the treatment of solid organ cancers, rapidly becoming a first line therapy with transformative durable response. While…
